메뉴 건너뛰기




Volumn 40, Issue 2, 1996, Pages 429-432

Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CLARITHROMYCIN; ETHAMBUTOL; KANAMYCIN; RIFALAZIL; RIFAMPICIN; RIFAMYCIN DERIVATIVE;

EID: 0030053503     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.429     Document Type: Article
Times cited : (10)

References (17)
  • 1
    • 0027971263 scopus 로고
    • Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection
    • Bermudez, L. E., P. Kolonoski, L. S. Young, and C. B. Inderlied. 1994 Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. Antimicrob. Agents Chemother. 38:1844-1848
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 1844-1848
    • Bermudez, L.E.1    Kolonoski, P.2    Young, L.S.3    Inderlied, C.B.4
  • 3
    • 0020511642 scopus 로고
    • An acute infection model for Mycobacterium intracellulare disease using beige mice, preliminary results
    • Gangadharam, P. R. J., C. K. Edwards III, P. S. Murthy, and P. F. Pratt. 1983. An acute infection model for Mycobacterium intracellulare disease using beige mice, preliminary results. Am. Rev Respir. Dis. 127:648-649.
    • (1983) Am. Rev Respir. Dis. , vol.127 , pp. 648-649
    • Gangadharam, P.R.J.1    Edwards III, C.K.2    Murthy, P.S.3    Pratt, P.F.4
  • 4
    • 0021986410 scopus 로고
    • Disseminated infection with Mycobacterium avium-intracellulare
    • Baltimore
    • Horsburgh, C. R., Jr., U. G. Mason III, D. C. Farhi, and M. D. Isema. 1985. Disseminated infection with Mycobacterium avium-intracellulare. Medicine (Baltimore) 64:36-48.
    • (1985) Medicine , vol.64 , pp. 36-48
    • Horsburgh Jr., C.R.1    Mason III, U.G.2    Farhi, D.C.3    Isema, M.D.4
  • 5
    • 0024586169 scopus 로고
    • The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS)
    • Horsburgh, C. R., Jr., and R. M. Selik. 1989. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis. 139:4-7.
    • (1989) Am. Rev. Respir. Dis. , vol.139 , pp. 4-7
    • Horsburgh Jr., C.R.1    Selik, R.M.2
  • 6
    • 0026457884 scopus 로고
    • Activity of clarithromycin against Mycobacterium avium complex infection in beige mice
    • Klemens, S. P., M. S. Destefano, and M. H. Cynamon. 1992. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 36:2413-2417.
    • (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 2413-2417
    • Klemens, S.P.1    Destefano, M.S.2    Cynamon, M.H.3
  • 7
    • 0021349515 scopus 로고
    • Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice
    • Kuze, F. 1984. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. Am. Rev Respir. Dis 129:453-459.
    • (1984) Am. Rev Respir. Dis , vol.129 , pp. 453-459
    • Kuze, F.1
  • 8
    • 0019616495 scopus 로고
    • In vitro and in vivo susceptibility of atypical mycobacteria to various drugs
    • Kuze, F., T. Kurasawa, K. Bando, Y. Lee, and N. Maekawa. 1981. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Rev. Infect. Dis. 3:885-897.
    • (1981) Rev. Infect. Dis. , vol.3 , pp. 885-897
    • Kuze, F.1    Kurasawa, T.2    Bando, K.3    Lee, Y.4    Maekawa, N.5
  • 9
    • 0025977668 scopus 로고
    • In vivo activities of new rifamycin derivatives against mycobacteria
    • Kuze, F., T. Yamamoto, R. Amitani, and K. Suzuki. 1990. In vivo activities of new rifamycin derivatives against mycobacteria. Kekkaku 66:7-12.
    • (1990) Kekkaku , vol.66 , pp. 7-12
    • Kuze, F.1    Yamamoto, T.2    Amitani, R.3    Suzuki, K.4
  • 10
    • 0024429064 scopus 로고
    • In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex
    • Naik, S., and R. Ruck. 1989. In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex Antimicrob. Agents Chemother. 33:1614-1616.
    • (1989) Antimicrob. Agents Chemother. , vol.33 , pp. 1614-1616
    • Naik, S.1    Ruck, R.2
  • 11
    • 0024472086 scopus 로고
    • Activity of rifabutin and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infection in mice
    • Saito, H., and K. Sato. 1989. Activity of rifabutin and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infection in mice. Tubercle 70:201-205.
    • (1989) Tubercle , vol.70 , pp. 201-205
    • Saito, H.1    Sato, K.2
  • 13
    • 0028945337 scopus 로고
    • Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice
    • Saito, H., H. Tomioka, K. Sato, S. Kawahara, T. Hidaka, and S. Dekio. 1995. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice Tubercle Lung Dis. 76:51-58.
    • (1995) Tubercle Lung Dis. , vol.76 , pp. 51-58
    • Saito, H.1    Tomioka, H.2    Sato, K.3    Kawahara, S.4    Hidaka, T.5    Dekio, S.6
  • 14
    • 0027446212 scopus 로고
    • In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method
    • Tomioka, H., H. Saito, K. Fujii, K. Sato, and T. Hidaka. 1993. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method Antimicrob. Agents Chemother. 37:67-70
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 67-70
    • Tomioka, H.1    Saito, H.2    Fujii, K.3    Sato, K.4    Hidaka, T.5
  • 15
    • 0026515252 scopus 로고
    • Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin. KRM-1648, against Mycobacterium avium complex infection induced in mice
    • Tomioka, H., H. Saito, K. Sato, T. Yamane, K. Yamashita, K. Hosoe, K. Fujii, and T. Hidaka. 1992. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin. KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrob. Agents Chemother. 36:387-393.
    • (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 387-393
    • Tomioka, H.1    Saito, H.2    Sato, K.3    Yamane, T.4    Yamashita, K.5    Hosoe, K.6    Fujii, K.7    Hidaka, T.8
  • 16
    • 0025634037 scopus 로고
    • In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex
    • In Japanese
    • Yamamoto, T., R. Amitani, F. Kuze, and K. Suzuki. 1990. In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex. Kekkaku 65:805-810. (In Japanese)
    • (1990) Kekkaku , vol.65 , pp. 805-810
    • Yamamoto, T.1    Amitani, R.2    Kuze, F.3    Suzuki, K.4
  • 17
    • 0023940190 scopus 로고
    • AIDS commentary. Mycobacterium avium complex infection
    • Young, L. S. 1988. AIDS commentary. Mycobacterium avium complex infection J. Infect. Dis. 157:863-867.
    • (1988) J. Infect. Dis. , vol.157 , pp. 863-867
    • Young, L.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.